Elsevier

Homeopathy

Volume 101, Issue 1, January 2012, Pages 21-27
Homeopathy

Original paper
Prospective observational study of 42 patients with atopic dermatitis treated with homeopathic medicines

https://doi.org/10.1016/j.homp.2011.09.002Get rights and content

Background

Atopic dermatitis (AD) is a highly prevalent chronic inflammatory skin disease which usually develops during childhood. Despite being a condition frequently treated with homeopathy, the evidence is still insufficient to define homeopathic treatment’s efficacy and the best therapeutic strategies.

Aims

To evaluate the effectiveness of homeopathic treatment of AD in a general homeopathic practice setting.

Methods

Patients spontaneously seeking homeopathic treatment meeting Hanifin and Rajka’s criteria were prospectively treated. Severity of disease was evaluated by Rajka and Langeland’s score and a set of four Visual Analogue Scales (VAS) evaluating disease severity, itch, general and psychological wellbeing and quality of sleep. Assessed outcomes were: change in AD extension, change in VASs, and a categorical scale for global subjective perception of evolution.

Results

Forty two patients were eligible. Twenty-one had other atopic comorbidities and 28 (66.7%) were moderate or severe cases. Sixteen (38.1%) patients dropped out. Significant differences were found comparing first and last consultations in mean percentage (95%CI) of affected skin area, 21.1% (10.9; 31.4) versus 5.5% (1.3; 9.7) respectively, P = 0.002, and in the change or the four VASs: [mm (95%CI)] AD 31.1 (20.6; 41.7), P < 0.0001; Itch 35.0 (23.6; 46.4), P < 0.0001; General wellbeing 11.1 (1.2; 20.9), P < 0.0188, and Sleep 17.4 (5.0; 29.8), P < 0.0073. Homeopathic aggravations were reported after 29.8% of prescriptions. Twelve individualized homeopathic medicines were prescribed; Sulphur accounted for 60% of cases with good treatment response.

Conclusions

This study suggests that in a general medical practice setting, homeopathic treatment could be regarded as an effective choice for patients with AD.

Introduction

Atopic dermatitis (AD) is a chronic itching inflammatory skin disease with a predilection for the skin flexures, which usually develops during early childhood. It is associated to high seric IgE and a personal or family history of AD, hay fever and/or bronchial asthma. Despite what its name suggests, up to 60% of children with AD do not have demonstrable IgE-mediated sensitivity to allergens. Approximately 70% of cases of AD start in children under age 5 years; 10% of cases begin in adulthood.1 Direct morbidity affects patients in many ways: sleep disturbance associated with itch, ostracism by other children and parents, need of special clothing and bedding, avoidance of some activities such as swimming, and the need of frequent application of greasy ointments and visits to the doctor.2 Asthma develops in approximately 30% of children with AD and allergic rhinitis in 35%.1 AD usually predates the development of asthma and allergic rhinitis, and it has been suggested that AD can be an entry point for subsequent allergic disease. Asthma is frequently more severe in children with coexistent AD than in children without AD.3

Prevalence of AD has risen steadily in Western industrialized and developing countries in the last decades,3 and according to surveys, it is currently about 10–30% in children and 1–3% in adults. In Latin America the prevalence of AD in children ranges from 3.2 to 25.0% in different regions (average 11.3%), and in teenagers from 3.4 to 30.2% (average 10.6%). Severe AD is found in 1.4% of the former and 1.5% of the latter.4 About 60% of affected children are apparently clear or free from symptoms by adolescence.1 But early onset, severe disease in childhood and associated asthma/hay fever are predictors of worse prognosis.2 Prognosis in adults with AD is worse than in children.2, 5

Conventional treatment includes topical corticosteroids and calcineurin inhibitors, emollients, oral antihistamine drugs and immunosuppressant agents, with varying effectiveness and potential adverse effects.1, 2, 6

AD is frequently seen in homeopathic practice. It probably accounts for one third of consultations for dermatologic disorders.7 Homeopathic treatment is believed to be effective in this disorder as in eczema in general,8, 9, 10, 11, 12, 13 including severe cases.14 But conclusive research defining its real efficacy and best homeopathic therapeutic strategies is still insufficient. In a recent comparative cohort study of homeopathic versus conventional treatment of 118 children with eczema over 12 months, both groups improved similarly regarding perception of eczema symptoms and health-related quality of life.8 A more recent randomized controlled trial (RCT) comparing homeopathic treatment versus placebo reported negative results, but the sample was too small and the number of drop-outs too high to infer any firm conclusion.15

Although the lack of sufficient research assessing homeopathic treatment of AD might lead to a negative view of its possible effectiveness, the fact that about half of patients with this disorder resort to alternative treatments16, 17 may be an indirect indicator of their dissatisfaction with conventional approaches.

The aim of this study is to evaluate the effectiveness of homeopathic treatment of AD in a general homeopathic practice setting and the frequency of prescribed homeopathic medicines.

Section snippets

Protocol and forms

A specific protocol was designed for the purpose of this study, based on a modified version of Dantas’ protocol for evaluation of homeopathic treatment of AD.18 In addition to the usual clinical-homeopathic form, a specific one was filled by physicians and patients in every visit, these forms were filed separately. In order to conceal assessments made in previous visits, neither practitioners nor patients were able to see the previously completed forms.

Patients and setting

Every patient spontaneously attending the

Patients’ characteristics and severity of disease at baseline

Forty two patients fulfilling inclusion criteria, age ranging from 2 months to 66 years old (median 6 years old), were recruited between 4 June 2003 and 23 August 2005. Two of the homeopaths quit the study soon after it began.

Half of the cases had atopic comorbidities at entry, mainly asthma (40.5%), allergic rhinitis (31.0%), or both (26.2%), and 76.2% had taken various conventional treatments for DA in the previous 2 weeks. Thirty six percent of patients had a history of more than 5 years since

Discussion

Although an observational study is considered relatively low grade of evidence, it has the advantage of showing what happens in the routine medical setting. Moreover, some issues about the study model and the patients’ characteristics might heighten the value of this type of research. That could be the case of chronic diseases with little tendency to spontaneous remission, patients with longstanding disease, with moderate to severe presentation, dissatisfied with previous conventional

Conclusions

This study suggests that on the basis of a general medicine practice setting, homeopathic treatment could be regarded as an effective choice for patients with AD.

Funding source

Costs of the study were supported by the authors.

Conflict of interest statement

No conflict of interest is declared.

Acknowledgments

We thank Silvia Waisse for a critical review of the manuscript and Esteban Rosberg for text revision. We also thank the homeopathic physicians that collaborated with this research, Francisco X. Eizayaga, Pedro B. Scala and Perla Aizenberg.

References (29)

  • E. Thompson et al.

    A preliminary audit investigating remedy reactions including adverse events in routine homeopathic practice

    Homeopathy

    (2004)
  • H.C. Williams

    Clinical practice. Atopic dermatitis

    N Engl J Med

    (2005)
  • C. Hoare et al.

    Systematic review of treatments for atopic eczema

    Health Technol Assess

    (2000)
  • L.F. Eichenfield et al.

    Atopic dermatitis and asthma: parallels in the evolution of treatment

    Pediatrics

    (2003)
  • Cited by (13)

    • Individualized homeopathy in a group of Egyptian asthmatic children

      2012, Homeopathy
      Citation Excerpt :

      The numbers who did not respond to treatment are also similar (10% in this study; 9% in Rossi;28 8.5% in Wassenhoven32). Drop-out incidence in our study (28.5%) was similar to that reported in other published observational studies of homeopathy (38.1% and 55.9%).28,35 In our study the percentage of patients lost to follow-up was lower among males than females (Figure 1).

    • Atopy and Hering's Law

      2012, Homeopathy
    View all citing articles on Scopus
    View full text